Asymmetric transfer hydrogenation of heterocycle-containing acetophenone derivatives using N-functionalised [(benzene)Ru(II)(TsDPEN)] complexes
作者:Jonathan Barrios-Rivera、Yingjian Xu、Guy J. Clarkson、Martin Wills
DOI:10.1016/j.tet.2021.132562
日期:2022.1
The application of enantiomerically-pure ruthenium(II) catalysts containing N - functionalised TsDPEN ligand to the asymmetric transferhydrogenation of 15 examples of α-heterocyclic acetophenone derivatives is reported. Products of up to 99% ee were formed.
报道了含有 N-官能化 TsDPEN 配体的对映体纯钌 (II) 催化剂在 15 个 α-杂环苯乙酮衍生物实例的不对称转移氢化中的应用。形成高达 99% ee 的产物。
Rhodium-catalyzed synthesis of unsymmetrical di(aryl/heteroaryl)methanes using aryl/heteroarylmethyl ketones via CO–C bond cleavage
作者:Guangzhe Li、Mieko Arisawa、Masahiko Yamaguchi
DOI:10.1039/c4cc00816b
日期:——
RhH(PPh3)4 and 1,2-bis(diphenylphosphino)benzene catalyze the reaction of aryl/heteroarylmethyl ketones and arylheteroaryl ethers giving unsymmetrical diarylmethanes containing one or two heteroarenes in high yields. The reaction does not use alkali metal bases, and therefore does not form large amounts of metal waste.
There are provided novel compounds of formula (I) wherein R1, R2 and R3 are as defined in the specification and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the kinase Itk.
A highly chemo- and regioselective Friedel–Craftsalkylation reaction of furans and thiophenes has been developed, which relies on the activation from the remote conjugated Mukaiyama silyl enol ether motif. Excellent enantioslectivity is generally obtained in reactions with α,β-unsaturated aldehydes under the well-established iminium ion catalysis of a chiral secondary amine.
[EN] 2-ACYLAMINOTHIAZOLE DERIVATIVES<br/>[FR] DERIVES DE 2-ACYLAMINOTHIAZOLE
申请人:LUNDBECK & CO AS H
公开号:WO2006032273A1
公开(公告)日:2006-03-30
The Invention relates to compounds of the formula I, wherein the variables are as defined in the claims, for use as a medicament. The compounds are A2A-receptor legends and are useful in the treatment of neurological and psychiatric disorders where an A2A-receptor is implicated.